NASDAQ:CELL Brightpoint (CELL) Stock Price, News & Analysis → The “Next Bitcoin”? 10 CENT Crypto Set to Explode (From True Market Insiders) (Ad) Free CELL Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$1.00▼$1.0050-Day Range$2.14▼$2.3152-Week Range N/AVolumeN/AAverage Volume676,796 shsMarket Capitalization$99.11 millionP/E RatioN/ADividend YieldN/APrice Target$1.50 Stock AnalysisStock Analysis Get Brightpoint alerts: Email Address Brightpoint MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside50.3% Upside$1.50 Price TargetShort InterestN/ADividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($1.03) to ($0.62) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.18 out of 5 starsMedical Sector759th out of 907 stocksAnalytical Instruments Industry23rd out of 26 stocks 3.0 Analyst's Opinion Consensus RatingBrightpoint has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageBrightpoint has received no research coverage in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for CELL. Previous Next 0.0 Dividend Strength Dividend YieldBrightpoint does not currently pay a dividend.Dividend GrowthBrightpoint does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CELL. Previous Next 0.6 News and Social Media Coverage Search InterestOnly 3 people have searched for CELL on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat Follows1 people have added Brightpoint to their MarketBeat watchlist in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Brightpoint insiders have not sold or bought any company stock.Percentage Held by Insiders17.60% of the stock of Brightpoint is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions58.39% of the stock of Brightpoint is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Brightpoint are expected to grow in the coming year, from ($1.03) to ($0.62) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Brightpoint is -0.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Brightpoint is -0.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioBrightpoint has a P/B Ratio of 0.51. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). About Brightpoint Stock (NASDAQ:CELL)Brightpoint, Inc.(BrightPoint) is engaged in providing device lifecycle services to the wireless industry. The Company provides customized logistic services, including demand planning, procurement, inventory management, software loading, kitting and customized packaging, fulfillment, credit services, receivables management, call center services, activation services, Website hosting, e-fulfillment solutions, repair, refurbish and recycle services, reverse logistics, transportation management and other services within the global wireless industry. The Company’s has three geographic segments, the Americas, EMEA and Asia-Pacific. Its customers include mobile network operators, mobile virtual network operators (MVNOs), resellers, retailers and wireless equipment manufacturers. In March 2011, the Company acquired the business and assets of C20 Mobile Pte. Ltd. and C20 Corporation Pte. Ltd. In October 2012, Ingram Micro Inc acquired Brightpoint.Read More Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). CELL Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive CELL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Brightpoint and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/25/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Analytical instruments Sub-IndustryN/A Current SymbolNASDAQ:CELL CUSIPN/A CIK918946 Webwww.brightpoint.com Phone+1-317-7072355FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Stock Price Target$1.50 High Stock Price Target$3.00 Low Stock Price Target$1.00 Potential Upside/Downside+50.3%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($1.55) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-98,040,000.00 Net Margins-173.40% Pretax Margin-173.20% Return on Equity-73.02% Return on Assets-44.23% Debt Debt-to-Equity RatioN/A Current Ratio2.24 Quick Ratio1.26 Sales & Book Value Annual Sales$78.60 million Price / Sales1.26 Cash FlowN/A Price / Cash FlowN/A Book Value$1.97 per share Price / Book0.51Miscellaneous Outstanding Shares99,300,000Free Float81,821,000Market Cap$99.11 million OptionableNot Optionable Beta0.84 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key CompetitorsSeerNASDAQ:SEERBionano GenomicsNASDAQ:BNGORapid Micro BiosystemsNASDAQ:RPIDSingular Genomics SystemsNASDAQ:OMICAkoya BiosciencesNASDAQ:AKYAView All Competitors CELL Stock Analysis - Frequently Asked Questions Should I buy or sell Brightpoint stock right now? 3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Brightpoint in the last twelve months. There are currently 3 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" CELL shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CELL, but not buy additional shares or sell existing shares. View CELL analyst ratings or view top-rated stocks. What is Brightpoint's stock price target for 2024? 3 Wall Street analysts have issued 1 year price objectives for Brightpoint's stock. Their CELL share price targets range from $1.00 to $3.00. On average, they anticipate the company's share price to reach $1.50 in the next twelve months. This suggests a possible upside of 50.3% from the stock's current price. View analysts price targets for CELL or view top-rated stocks among Wall Street analysts. What other stocks do shareholders of Brightpoint own? Based on aggregate information from My MarketBeat watchlists, some companies that other Brightpoint investors own include (VMED) (VMED), TiVo (TIVO), RTX (RTX), Broadcom (AVGO). This page (NASDAQ:CELL) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsYour Money is Not SafeAmerican AlternativeFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Brightpoint, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
